Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: DOSING OF A BISPECIFIC ANTIBODY THAT BIND CD123 AND CD3 Filling date: 23 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: HEPATITIS B ANTIBODIES Filling date: 23 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: METHOD FOR DECREASING IMMUNOGENICITY Filling date: 23 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: COMBINATION THERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES Filling date: 23 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: DOSING OF A BISPECIFIC ANTIBODY THAT BIND CD123 AND CD3 Filling date: 23 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: Solid Support Filling date: 23 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBIT0R Filling date: 23 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: USE OF IL-1 BETA BINDING ANTIBODIES TO TREAT PERIPHERAL ARTERIAL DISEASE Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: Automatic Drug Delivery Device Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: Automatic Drug Delivery Device Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: Automatic Drug Delivery Device Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: Automatic Drug Delivery Device Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: MULTISPECIFIC MOLECULES TARGETING CLL-1 Filling date: 23 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS Filling date: 23 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: COMBINATION OF RIBOCICLIB AND DABRAFENIB FOR TREATING OR PREVENTING CANCER Filling date: 23 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: AZA-INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES Filling date: 23 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: COMBINATIONS COMPRISING TROPIFEXOR AND CENICRIVIROC Filling date: 23 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: METHODS OF TREATING AUTO-INFLAMMATORY SYNDROMES USING IL-1BETA ANTIBODIES Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: CD19 AND CD22 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: NEW PHARMACEUTICAL USE FOR THE TREATMENT OF HEART FAILURE Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: EXTENDED RELEASE FORMULATIONS FOR INTRA-ARTICULAR APPLICATIONS Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: SYNTHETIC RNAS AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: ANTI-CAR COMPOSITIONS AND METHODS Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELLS Filling date: 23 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: FGF21 Mimetic Antibodies and Uses Thereof Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulation Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANTIGEN RECEPTOR THERAPY AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Pharmaceutical Composition Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR?EXPRESSING CELLS Filling date: 23 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: SYRINGE Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: Octreotide Depot Formulation with Constantly High Exposure Levels Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: IMMUNOSUPPRESSANT FORMULATION Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: COMBINATION THERAPY FOR THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: Ceritinib Formulation Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: POLYMERIC DRUG CONJUGATES WITH TETHER GROUPS FOR CONTROLLED DRUG DELIVERY Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: ENTPD2 ANTIBODIES, COMBINATION THERAPIES, AND METHODS OF USING THE ANTIBODIES AND COMBINATION THERAPIES Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COMPOSITIONS AND METHODS TO TREAT CANCER Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR TREATING SOLID TUMORS BY INTRATUMORAL ADMINISTRATION Filling date: 23 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: Methods of Using IL-1beta Compounds Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: NEW THERAPEUTIC USES Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Showing 200 to 250 of 676 patents.